Yu H - Search Results

1

Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.

Xin H, Zhang C, Herrmann A, Du Y, Figlin R, Yu H. Xin H, et al. Among authors: yu h. Cancer Res. 2009 Mar 15;69(6):2506-13. doi: 10.1158/0008-5472.CAN-08-4323. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244102 Free PMC article.

2

Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.

Ravi R, Jain AJ, Schulick RD, Pham V, Prouser TS, Allen H, Mayer EG, Yu H, Pardoll DM, Ashkenazi A, Bedi A. Ravi R, et al. Among authors: yu h. Cancer Res. 2004 Dec 15;64(24):9105-14. doi: 10.1158/0008-5472.CAN-04-2488. Cancer Res. 2004. PMID: 15604280

3

Targeting STAT3 affects melanoma on multiple fronts.

Kortylewski M, Jove R, Yu H. Kortylewski M, et al. Among authors: yu h. Cancer Metastasis Rev. 2005 Jun;24(2):315-27. doi: 10.1007/s10555-005-1580-1. Cancer Metastasis Rev. 2005. PMID: 15986140 Review.

4

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

Yu H, Kortylewski M, Pardoll D. Yu H, et al. Nat Rev Immunol. 2007 Jan;7(1):41-51. doi: 10.1038/nri1995. Nat Rev Immunol. 2007. PMID: 17186030 Review.

5

Stat3 as a potential target for cancer immunotherapy.

Kortylewski M, Yu H. Kortylewski M, et al. Among authors: yu h. J Immunother. 2007 Feb-Mar;30(2):131-9. doi: 10.1097/01.cji.0000211327.76266.65. J Immunother. 2007. PMID: 17471161 Review.

6

Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.

Buettner R, Huang M, Gritsko T, Karras J, Enkemann S, Mesa T, Nam S, Yu H, Jove R. Buettner R, et al. Among authors: yu h. Mol Cancer Res. 2007 Aug;5(8):823-32. doi: 10.1158/1541-7786.MCR-06-0352. Mol Cancer Res. 2007. PMID: 17699108

7

Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity.

Harris TJ, Grosso JF, Yen HR, Xin H, Kortylewski M, Albesiano E, Hipkiss EL, Getnet D, Goldberg MV, Maris CH, Housseau F, Yu H, Pardoll DM, Drake CG. Harris TJ, et al. Among authors: yu h. J Immunol. 2007 Oct 1;179(7):4313-7. doi: 10.4049/jimmunol.179.7.4313. J Immunol. 2007. PMID: 17878325

8

Role of Stat3 in suppressing anti-tumor immunity.

Kortylewski M, Yu H. Kortylewski M, et al. Among authors: yu h. Curr Opin Immunol. 2008 Apr;20(2):228-33. doi: 10.1016/j.coi.2008.03.010. Epub 2008 May 12. Curr Opin Immunol. 2008. PMID: 18479894 Free PMC article. Review.

9

Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells.

Niu G, Briggs J, Deng J, Ma Y, Lee H, Kortylewski M, Kujawski M, Kay H, Cress WD, Jove R, Yu H. Niu G, et al. Among authors: yu h. Mol Cancer Res. 2008 Jul;6(7):1099-105. doi: 10.1158/1541-7786.MCR-07-2177. Mol Cancer Res. 2008. PMID: 18644974 Free PMC article.

10

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.

Kujawski M, Kortylewski M, Lee H, Herrmann A, Kay H, Yu H. Kujawski M, et al. Among authors: yu h. J Clin Invest. 2008 Oct;118(10):3367-77. doi: 10.1172/JCI35213. J Clin Invest. 2008. PMID: 18776941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36,816 results

Search Page